相似文献
1
Fertility preservation for patients with gynecologic malignancies: The Korean Society for Fertility Preservation clinical guidelines.
Clin Exp Reprod Med. 2017 Dec;44(4):175-180. doi: 10.5653/cerm.2017.44.4.175. Epub 2017 Dec 31.
2
Fertility preservation in women with cancer.
Clin Exp Reprod Med. 2012 Jun;39(2):46-51. doi: 10.5653/cerm.2012.39.2.46. Epub 2012 Jun 30.
3
Fertility preservation in women with early-stage gynecologic cancer: optimizing oncologic and reproductive outcomes.
Int J Gynecol Cancer. 2021 Mar;31(3):345-351. doi: 10.1136/ijgc-2020-001328. Epub 2020 Jun 21.
4
Fertility after the treatment of gynecologic tumors.
Recent Results Cancer Res. 2008;178:79-95. doi: 10.1007/978-3-540-71274-9_9.
5
Fertility preserving management in gynecologic cancer patients: the need for centralization.
Int J Gynecol Cancer. 2010 Dec;20(9):1613-9. doi: 10.1111/IGC.0b013e3181f936ff.
6
Fertility considerations prior to conservative management of gynecologic cancers.
Int J Gynecol Cancer. 2021 Mar;31(3):339-344. doi: 10.1136/ijgc-2020-001783. Epub 2020 Nov 11.
7
Factors influencing fertility-sparing treatment for gynecologic malignancies: A survey of Society of Gynecologic Oncology members.
Gynecol Oncol. 2017 Dec;147(3):497-502. doi: 10.1016/j.ygyno.2017.09.019. Epub 2017 Sep 21.
8
Fertility preservation for patients with hematologic malignancies: The Korean Society for Fertility Preservation clinical guidelines.
Clin Exp Reprod Med. 2017 Dec;44(4):187-192. doi: 10.5653/cerm.2017.44.4.187. Epub 2017 Dec 31.
9
Fertility preserving treatment for gynecologic malignancies: a review of recent literature.
Curr Opin Obstet Gynecol. 2020 Feb;32(1):51-56. doi: 10.1097/GCO.0000000000000604.
10
A prospective study of women and girls undergoing fertility preservation due to oncologic and non-oncologic indications in Sweden-Trends in patients' choices and benefit of the chosen methods after long-term follow up.
Acta Obstet Gynecol Scand. 2019 May;98(5):604-615. doi: 10.1111/aogs.13559. Epub 2019 Mar 18.
引用本文的文献
1
Awareness and perceptions of Filipino obstetrician-gynecologists on fertility preservation: a cross-sectional survey.
BMC Womens Health. 2023 May 25;23(1):285. doi: 10.1186/s12905-023-02436-7.
2
Role of Stem Cells in the Ovarian Tissue Cryopreservation and Transplantation for Fertility Preservation.
Int J Mol Sci. 2021 Nov 19;22(22):12482. doi: 10.3390/ijms222212482.
3
Molecular Mechanism and Prevention Strategy of Chemotherapy- and Radiotherapy-Induced Ovarian Damage.
Int J Mol Sci. 2021 Jul 13;22(14):7484. doi: 10.3390/ijms22147484.
4
Changes in telomere length and senescence markers during human ovarian tissue cryopreservation.
Sci Rep. 2021 Jan 26;11(1):2238. doi: 10.1038/s41598-021-81973-3.
5
Magnetic resonance relaxometry improves the accuracy of conventional MRI in the diagnosis of endometriosis-associated ovarian cancer: A case report.
Mol Clin Oncol. 2019 Sep;11(3):296-300. doi: 10.3892/mco.2019.1889. Epub 2019 Jul 1.
6
Comparison between Slow Freezing and Vitrification for Human Ovarian Tissue Cryopreservation and Xenotransplantation.
Int J Mol Sci. 2019 Jul 8;20(13):3346. doi: 10.3390/ijms20133346.
7
Investigation of Each Society for Fertility Preservation in Asia.
Front Endocrinol (Lausanne). 2019 Mar 14;10:151. doi: 10.3389/fendo.2019.00151. eCollection 2019.
8
Ovarian tissue cryopreservation and transplantation in patients with cancer.
Obstet Gynecol Sci. 2018 Jul;61(4):431-442. doi: 10.5468/ogs.2018.61.4.431. Epub 2018 Jun 28.
本文引用的文献
1
Myeloproliferative Neoplasms, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw. 2016 Dec;14(12):1572-1611. doi: 10.6004/jnccn.2016.0169.
2
Practice guidelines for management of uterine corpus cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement.
J Gynecol Oncol. 2017 Jan;28(1):e12. doi: 10.3802/jgo.2017.28.e12. Epub 2016 Oct 27.
3
Fertility-sparing management in cervical cancer: balancing oncologic outcomes with reproductive success.
Gynecol Oncol Res Pract. 2016 Oct 21;3:9. doi: 10.1186/s40661-016-0030-9. eCollection 2016.
4
Long-term results of fertility-sparing treatment compared with standard radical surgery for early-stage epithelial ovarian cancer.
Br J Cancer. 2016 Sep 6;115(6):641-8. doi: 10.1038/bjc.2016.254. Epub 2016 Aug 18.
5
Fertility results and pregnancy outcomes after conservative treatment of cervical cancer: a systematic review of the literature.
Fertil Steril. 2016 Oct;106(5):1195-1211.e5. doi: 10.1016/j.fertnstert.2016.06.032. Epub 2016 Jul 16.
6
Oncological outcomes after fertility-sparing surgery for cervical cancer: a systematic review.
Lancet Oncol. 2016 Jun;17(6):e240-e253. doi: 10.1016/S1470-2045(16)30032-8.
7
Progestins in the fertility-sparing treatment and retreatment of patients with primary and recurrent endometrial cancer.
Oncologist. 2015 Mar;20(3):270-8. doi: 10.1634/theoncologist.2013-0445. Epub 2015 Feb 11.
8
Conservative surgery in ovarian borderline tumours: a meta-analysis with emphasis on recurrence risk.
Eur J Cancer. 2015 Mar;51(5):620-31. doi: 10.1016/j.ejca.2015.01.004. Epub 2015 Feb 3.
9
Fertility sparing surgery in early stage epithelial ovarian cancer.
J Gynecol Oncol. 2014 Oct;25(4):320-7. doi: 10.3802/jgo.2014.25.4.320. Epub 2014 Jun 18.
10
Endometrial cancer: a review and current management strategies: part II.
Gynecol Oncol. 2014 Aug;134(2):393-402. doi: 10.1016/j.ygyno.2014.06.003. Epub 2014 Jun 11.
Zotero 插件